English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/178711
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Intraorganellar acidification by V-ATPases: A target in cell proliferation and cancer therapy

AuthorsHernández, Agustín ; Serrano, Gloria; Herrera-Palau, Rosana ; Pérez-Castiñeira, J. R. ; Serrano, Aurelio
KeywordsChondropsin
Concanamycin
Salicylihalamide
Bafilomycin
V-ATPase
Issue Date2010
PublisherBentham Science Publishers
CitationRecent Patents on Anti-Cancer Drug Discovery 5: 88- 98 (2010)
AbstractV-ATPases are multicomponent proton pumps involved in the acidification of single membrane intracellular compartments such as endosomes and lysosomes. They couple the hydrolysis of ATP to the translocation of one to two protons across the membrane. Acidification of the lumen of single membrane organelles is a necessary factor for the correct traffic of membranes and cargo to and from the different internal compartments of a cell. Also, V-ATPases are involved in regulation of pH at the cytosol and, possibly, extracellular milieu. The inhibition of V-ATPases has been shown to induce apoptosis and cell cycle arrest in tumour cells and, therefore, chemicals that behave as inhibitors of this kind of proton pumps have been proposed as putative treatment agents against cancer. The present review will summarize the major types of V-ATPase inhibitors and their mechanisms of action and put them in relation to the patents registered so far for the treatment of cancer.
URIhttp://hdl.handle.net/10261/178711
Identifiersissn: 1574-8928
Appears in Collections:(IBVF) Artículos
Files in This Item:
File Description SizeFormat 
Intraorganellar acidification by V-ATPases_paraCSIC.pdf434,13 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.